Ecolab (ECL) Earnings Date & Reports

Key Takeaways

• Ecolab reported Q2 2026 adjusted diluted EPS of $2.09, surpassing the Zacks Consensus Estimate of $2.08 by 0.4% and rising 11% year over year.
• Revenue reached $4.42 billion, beating the consensus estimate of $4.39 billion and climbing 9.7% compared to the same quarter last year.
• Organic sales growth accelerated to 5%, driven by 4% pricing improvement and 1% volume growth despite a nearly 1% headwind from Middle East disruptions.
• Global High-Tech and Life Sciences led the charge, delivering organic sales growth of 29% and 15%, respectively.
• Management raised its full-year 2026 adjusted EPS guidance to a range of $8.05 to $8.25, up from the prior range of $8.03 to $8.23.
• Ecolab shares rose approximately 1.3% in pre-market trading following the release, reflecting a broadly positive market reception.

Earnings Context and Why It Matters

Ecolab's second-quarter results, released before the opening bell on July 28, 2026, arrived at a pivotal moment for the water, hygiene, and infection prevention giant. The quarter was framed by management as a "transition period," with elevated commodity, energy, and logistics costs pressuring margins before pricing actions and recently implemented energy surcharges could fully catch up. Against this backdrop, the report served as a crucial test of Ecolab's pricing power and its ability to maintain margin discipline. With the S&P 500 up 8.3% year to date and Ecolab trailing at roughly 3.4% heading into the release, investors were keenly focused on whether the company's growth engines — particularly Global High-Tech and Life Sciences — could sustain their momentum and whether organic margin expansion remained achievable.

Reported Results

Ecolab posted second-quarter 2026 net sales of $4,415.4 million, representing a 9.7% increase from $4,025.2 million in the prior-year period. Organic sales, which exclude the impact of acquisitions, divestitures, and foreign currency translation, rose 5% to $4,282.1 million. The Zacks Consensus Estimate had called for revenue of $4.39 billion, meaning the top-line result came in modestly ahead of expectations.

On the bottom line, reported (GAAP) diluted earnings per share (EPS) came in at $1.90, up 3.3% from $1.84 a year ago. Adjusted diluted EPS, which strips out special gains and charges and discrete tax items, reached $2.09 — an 11% increase from $1.89 in Q2 2025 and $0.01 above the consensus estimate of $2.08. The adjusted figure more accurately reflects the company's underlying operating performance.

Reported operating income increased 7% to $757.9 million, while adjusted operating income rose 10% to $809.0 million. The organic operating income margin expanded 40 basis points year over year to 18.8%, as accelerating pricing more than offset higher commodity costs and growth-oriented investments. Adjusted gross margin declined 60 basis points to 44.2%, reflecting the impact of the Ovivo Electronics acquisition; excluding that impact, organic gross margin was stable.

Segment-level performance underscored the breadth of the quarter's strength. Global Water posted organic sales growth of 4%, anchored by 29% growth in Global High-Tech. Global Institutional & Specialty delivered 4% organic growth, while Global Pest Elimination and Global Life Sciences grew 7% and 15% organically, respectively. Digital sales surged 27% to $121 million.

AI Screener

For investors seeking to identify opportunities beyond a single company's earnings report, Tickeron's AI Screener offers a powerful, AI-driven platform for filtering thousands of stocks and ETFs based on technical patterns, fundamental health, volatility profiles, and proprietary AI signals. Users can customize screens by industry, market capitalization, specific technical indicators, price patterns, and performance metrics to surface trade ideas, breakout candidates, and trending stocks far more efficiently than manual research allows. Whether scanning for momentum setups following earnings catalysts like Ecolab's or identifying undervalued names with improving fundamentals, the AI Screener helps streamline the discovery process. Explore the screener to see how AI-powered filtering can complement your market research.

Market Reaction and Investor Sentiment

Ecolab shares rose approximately 1.3% in pre-market trading on July 28, with the stock changing hands around $275.00, up from the prior close. While the initial move was positive, it remained relatively measured — consistent with a modest earnings beat that confirmed the company's pricing strategy is working without delivering a blowout surprise. Heading into the release, sentiment had been cautiously optimistic but tempered by the Zacks Rank #4 (Sell) rating assigned to the stock, which reflected a trend of unfavorable earnings estimate revisions. The raised full-year guidance appeared to be the most important signal for investors, as it validated management's confidence that accelerating pricing in the second half of 2026 would fully offset ongoing commodity cost pressure. The market's restrained but constructive response suggests investors are giving management the benefit of the doubt on the "transition quarter" narrative.

Forward Outlook and Key Factors to Monitor

Ecolab enters the second half of 2026 with meaningfully improved momentum. Management raised full-year adjusted EPS guidance to $8.05–$8.25 (7%–10% growth) and set third-quarter adjusted EPS expectations at $2.13–$2.23, representing 3%–8% growth. Organic sales growth is expected to accelerate to a 6%–7% range in the second half, and the company anticipates an organic operating income margin of approximately 20% for the period.

Several factors will determine whether Ecolab can deliver on this outlook. First, the trajectory of commodity, energy, and logistics costs remains a key variable. Management expects total pricing in the second half to land in the 5%–6% range as energy surcharges take full effect, which is central to the margin recovery story. Second, the recent close of the CoolIT acquisition extends Ecolab's reach into the rapidly expanding AI infrastructure market, and investors will watch closely for integration updates and the pace of revenue contribution. Third, geopolitical headwinds — particularly customer disruptions in the Middle East, which shaved nearly 1% from volume growth in Q2 — could persist or ease, affecting the volume component of organic growth.

Additionally, the performance of Ecolab's growth engines will remain under scrutiny. Global High-Tech is now approaching $1.5 billion in annualized sales, and management projects it will reach $4 billion by 2030. Sustaining the 29% organic growth rate posted in Q2 is a high bar, but continued AI infrastructure investment and semiconductor fabrication demand provide a strong demand tailwind. Life Sciences, Pest Elimination, and Digital also represent multi-year growth opportunities that together form the foundation of Ecolab's long-term 12%–15% adjusted EPS growth algorithm. The second half will reveal whether the pricing, volume, and productivity levers Ecolab has pulled can work in concert to deliver on that ambition.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations